Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Stats
Total: 97 #1
CompanyFluidigm Corporation
IndustryMedical Laboratories & Research
Market Cap353.40MEPS (ttm)-1.37
P/E-EPS this Y18.90%
Forward P/E-EPS next Y32.30%
PEG-EPS past 5Y-18.10%
P/S2.95EPS next 5Y-8.06%
P/B2.04EPS Q/Q52.20%
Dividend-Sales Q/Q6.80%
Insider Own0.70%Inst Own96.50%
Insider Trans-80.95%Inst Trans0.51%
Short Float2.34%EarningsNov 05/a
Analyst Recom1.80Target Price10.70
Avg Volume741.54K52W Range4.03 - 14.90
Nov-06-19Downgrade Janney Buy → Neutral
Nov-06-19 02:08AMEdited Transcript of FLDM earnings conference call or presentation 5-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-05-19 07:55PMFluidigm (FLDM) Reports Q3 Loss, Misses Revenue Estimates Zacks
Nov-05-19 04:05PMFluidigm Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 04:02PMFluidigm Drives a New Standard in Human Immune Profiling GlobeNewswire
Nov-01-19 08:17AMEstimating The Fair Value Of Fluidigm Corporation (NASDAQ:FLDM) Simply Wall St.
Oct-29-19 10:33AMFluidigm (FLDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-28-19 08:23PMFluidigm Corporation (FLDM) Is Burning These Hedge Funds Insider Monkey
Oct-15-19 04:15PMFluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting GlobeNewswire
Oct-10-19 04:10PMFluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results GlobeNewswire
Sep-26-19 09:16AMDoes Fluidigm Corporation's (NASDAQ:FLDM) CEO Salary Compare Well With Others? Simply Wall St.
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. It sells instruments and consumables, including IFCs, assays, and reagents to academic institutions, clinical research laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The company sells its products to academic institutions, life sciences, and clinical research laboratories that conduct research, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Levin Easterly Partners LLCPassive InvestorSep 17Sale5.40577,1973,116,8646,909,871Sep 19 04:27 PM
Levin Easterly Partners LLCPassive InvestorSep 11Sale5.5511,54564,1127,487,068Sep 13 04:22 PM
COLELLA SAMUEL DDirectorAug 27Buy5.192,00010,372119,481Aug 28 09:13 PM
Linthwaite Stephen ChristopherPresident & CEOAug 23Buy5.524,00022,077171,391Aug 27 07:58 PM
Khadder NicholasSee RemarksAug 20Option Exercise0.004,901042,962Aug 22 05:54 PM
TickerPLT [NYSE]
CompanyPlantronics, Inc.
IndustryCommunication Equipment
Market Cap1.52BEPS (ttm)-5.05
P/E-EPS this Y-243.20%
Forward P/E6.13EPS next Y12.37%
PEG-EPS past 5Y-27.90%
P/S0.80EPS next 5Y15.00%
P/B2.31EPS Q/Q-362.40%
Dividend1.52%Sales Q/Q102.30%
Insider Own1.50%Inst Own98.76%
Insider Trans-0.75%Inst Trans1.50%
Short Float10.13%EarningsNov 05/a
Analyst Recom1.80Target Price63.80
Avg Volume446.16K52W Range26.09 - 62.97
Nov-06-19Downgrade Northland Capital Outperform → Market Perform $70 → $35
Nov-06-19 08:04AMPlantronics Stock Is Plunging on Weak Earnings and a Soft Outlook
Nov-06-19 04:08AMEdited Transcript of PLT earnings conference call or presentation 5-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-05-19 05:55PMPlantronics (PLT) Misses Q2 Earnings and Revenue Estimates Zacks
Nov-05-19 04:57PMPlantronics stock plunges more than 25% after earnings guidance slashed MarketWatch
Nov-05-19 04:05PMPoly Announces Second Quarter Fiscal Year 2020 Financial Results PR Newswire
Nov-04-19 09:00AMPoly Introduces Poly Studio X Series for Microsoft Teams at Microsoft Ignite 2019 PR Newswire
Oct-30-19 08:15AM8x8, Poly and ScanSource Announce Strategic Partnership to Deliver Communications Industrys First Comprehensive Move to Cloud Program Business Wire
Oct-29-19 10:33AMPlantronics (PLT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-26-19 12:35PMIs Plantronics, Inc. (PLT) A Good Stock To Buy? Insider Monkey
Oct-22-19 09:00AMPoly Announces Date of Second Quarter 2020 Earnings Release and Investor Day PR Newswire
Plantronics, Inc. designs, manufactures, and markets various integrated communications and collaborations solutions for corporate customers, small businesses, and individuals worldwide. Its principal product categories include enterprise headsets, which comprise corded and cordless communication headsets; consumer headsets, such as Bluetooth and corded products for mobile device applications, personal computer, and gaming; voice, video, and content sharing solutions that include Open SIP desktop and conference room phones, and video endpoints designed to work with a range of unified communication and collaboration, unified communication as a service, and video as a service environments, including RealPresence collaboration solutions of infrastructure to endpoints that allows people to connect and collaborate; and support services. The company sells its products through a sales team, as well as through value-added resellers, integrators, direct marketing resellers, service providers, resellers, retailer, office supply distributors, wireless carriers, catalog and mail order companies, and mass merchants under the Poly, Plantronics, and Polycom brands, as well as RIG sub-brand. Plantronics, Inc. was founded in 1961 and is headquartered in Santa Cruz, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURTON JOSEPH BCEO - CORPORATE - GLOBAL.E0.Sep 09Option Exercise32.945,000164,700156,960Sep 11 05:42 PM
BURTON JOSEPH BCEO - CORPORATE - GLOBAL.E0.Sep 09Sale33.005,000165,000151,960Sep 11 05:42 PM
LOEBBAKA JEFFTOP SALES EXECUTIVE - GLOBAL.EMay 14Sale44.031,33458,73639,292May 15 06:58 PM
BOYNTON CHARLES DTOP FINANCIAL EXECUTIVE - CFO.May 10Buy42.802,00085,59736,611May 13 09:05 AM
TSEU MARVINDirectorFeb 21Option Exercise36.804,238155,95824,876Feb 22 05:17 PM
TickerBXC [NYSE]
CompanyBlueLinx Holdings Inc.
IndustryBuilding Materials Wholesale
Market Cap285.51MEPS (ttm)-2.85
P/E-EPS this Y-152.10%
Forward P/E19.38EPS next Y171.19%
PEG-EPS past 5Y-0.50%
P/S0.10EPS next 5Y25.00%
P/B-EPS Q/Q172.50%
Dividend-Sales Q/Q-20.90%
Insider Own3.10%Inst Own91.86%
Insider Trans36.94%Inst Trans5.91%
Short Float14.69%EarningsNov 05/a
Analyst Recom2.00Target Price28.00
Avg Volume113.67K52W Range17.88 - 35.40
Nov-05-19 04:34PMBlueLinx Announces 2019 Third Quarter Financial Results GlobeNewswire
Oct-25-19 08:16AMIntroducing BlueLinx Holdings (NYSE:BXC), The Stock That Soared 348% In The Last Three Years Simply Wall St.
Oct-24-19 01:43PMBlueLinx to Host Third Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire
Sep-19-19 10:01AMShould You Take Comfort From Insider Transactions At BlueLinx Holdings Inc. (NYSE:BXC)? Simply Wall St.
Sep-11-19 06:43PMEdited Transcript of BXC earnings conference call or presentation 7-Aug-19 2:00pm GMT Thomson Reuters StreetEvents
Sep-10-19 06:19PMBlueLinx Announces Sale of Former Distribution Facility GlobeNewswire
Sep-06-19 12:14PMBlueLinx to Present at D.A. Davidson 18th Annual Diversified Industrials and Services Conference on September 19, 2019 GlobeNewswire
Aug-22-19 08:08AMWood Industry Outlook Hit by Low Lumber Prices, Soft Housing Zacks
Aug-19-19 09:44AMMoistureShield Collaborates with BlueLinx Atlanta and Chicago Locations to Distribute Composite Decking & Railing GlobeNewswire
Aug-14-19 11:31AMHow Should Investors React To BlueLinx Holdings Inc.'s (NYSE:BXC) CEO Pay? Simply Wall St.
BlueLinx Holdings Inc., together with its subsidiaries, distributes building and industrial products in the United States. It distributes structural products, including plywood, oriented strand board, rebar and remesh, lumber, spruce, and other wood products primarily used for structural support, walls, and flooring in construction projects; and specialty products comprising engineered wood, moulding, siding, cedar, metal, and insulation products. The company also provides a range of value-added services and solutions to its customers. It serves dealers, industrial manufacturers, manufactured housing producers, and home improvement retailers through a network of distribution centers. BlueLinx Holdings Inc. was founded in 1996 and is headquartered in Marietta, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewis Mitchell BPRESIDENT AND CEOAug 22Buy26.991,20032,388158,912Aug 23 06:59 PM
Nokomis Capital, L.L.C.10% OwnerJul 09Buy18.602,33543,4311,281,804Jul 11 05:06 PM
Nokomis Capital, L.L.C.10% OwnerJul 05Buy18.1773,4761,335,0591,279,469Jul 09 04:05 PM
Nokomis Capital, L.L.C.10% OwnerDec 26Buy20.31105,9892,152,8921,205,993Dec 28 04:05 PM
Nokomis Capital, L.L.C.10% OwnerDec 24Buy20.4849,1171,005,8421,100,004Dec 27 04:08 PM
CompanyNeonode Inc.
IndustryDiversified Electronics
Market Cap18.94MEPS (ttm)-0.45
P/E-EPS this Y41.50%
Forward P/E-EPS next Y30.00%
PEG-EPS past 5Y32.50%
P/S2.37EPS next 5Y25.00%
P/B2.04EPS Q/Q12.70%
Dividend-Sales Q/Q-10.50%
Insider Own0.10%Inst Own4.80%
Insider Trans0.00%Inst Trans-
Short Float5.87%EarningsNov 14/b
Analyst Recom-Target Price3.00
Avg Volume6.78K52W Range1.31 - 3.80
Nov-06-19 09:31AMNeonode Reports Third Quarter Ended September 30, 2019 Financial Results PR Newswire
Oct-23-19 09:31AMNeonode Announces Appointment of New CEO PR Newswire
Sep-30-19 08:49AMNeonode: Robust, Responsive and Cost Effective Touch In Cars PR Newswire
Aug-14-19 09:32AMNeonode Reports Second Quarter Ended June 30, 2019 Financial Results PR Newswire
Jun-26-19 10:32AMNeonode Announces Contactless Touch for Curbing Pathogen Transmission in Hospitals and Other Public Spaces PR Newswire
May-28-19 09:44AMNeonode Announces Appointment of New Chief Financial Officer PR Newswire
May-13-19 10:12AMNeonode Announces Next Generation of Cost Optimized Touch Solutions and Extends Range of Sensor Modules PR Newswire
May-08-19 09:39AMNeonode Reports First Quarter Ended March 31, 2019 Financial Results PR Newswire
May-08-19 09:37AMNeonode: 1Q Earnings Snapshot Associated Press
Apr-15-19 09:31AMNeonode and Finetek Sign Collaboration Agreement PR Newswire
Neonode Inc., together with its subsidiaries, develops and licenses user interface and optical interactive touch solutions under the zForce brand in the United States, Japan, Germany, China, Taiwan, South Korea, and internationally. It develops optical touch and gesture solutions for human interaction with devices. The company licenses its touch technology to original equipment manufacturers and Tier 1 suppliers. It also provides engineering consulting services. In addition, the company sells Neonode branded sensor products, such as AirBar PC touch products through distributors and directly to consumers. Neonode Inc. was incorporated in 1997 and is based in Stockholm, Sweden.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lindqvist Lars, GoranCFODec 28Buy1.604,3757,0009,375Jan 02 05:24 PM
Persson HakanChief Executive OfficerDec 28Buy1.6034,37555,00034,375Jan 02 05:22 PM
Bunge AndreasDirectorDec 28Buy1.6029,00046,400104,000Jan 02 05:21 PM
Rosberg UlfDirectorDec 28Buy1.601,138,7961,822,0741,589,956Jan 02 05:20 PM
CompanySupernus Pharmaceuticals, Inc.
IndustryDrugs - Generic
Market Cap1.53BEPS (ttm)1.94
P/E15.00EPS this Y63.20%
Forward P/E14.73EPS next Y-9.60%
PEG0.41EPS past 5Y22.00%
P/S3.73EPS next 5Y37.00%
P/B2.92EPS Q/Q7.00%
Dividend-Sales Q/Q5.20%
Insider Own1.10%Inst Own98.94%
Insider Trans1.27%Inst Trans-0.46%
Short Float12.33%EarningsNov 05/a
Analyst Recom1.70Target Price50.83
Avg Volume564.35K52W Range24.77 - 49.25
Nov-06-19Downgrade Jefferies Buy → Hold $46 → $23
Nov-05-19 06:45PMSupernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Lag Estimates Zacks
Nov-05-19 04:55PMSupernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients GlobeNewswire
Oct-29-19 10:32AMSupernus Pharmaceuticals (SUPN) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-28-19 08:53AMWere Hedge Funds Right About Dumping Supernus Pharmaceuticals Inc (SUPN)? Insider Monkey
Oct-24-19 04:10PMSupernus to Host Third Quarter 2019 Earnings Conference Call GlobeNewswire
Oct-22-19 03:49PMEstimating The Fair Value Of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Simply Wall St.
Oct-02-19 01:04PMSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Insiders Increased Their Holdings Simply Wall St.
Sep-25-19 02:21PMSupernus to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-13-19 01:54PM5 Health Care Stocks Gurus Are Buying
Sep-02-19 09:50AMHow Does Investing In Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Impact The Volatility Of Your Portfolio? Simply Wall St.
Supernus Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy and migraine. The company's product candidates comprise SPN-812, a viloxazine hydrochloride, which is in Phase III clinical trial that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with ADHD; SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression; SPN-604 extended release oxcarbazepine for bipolar; and SPN-817 that is in phase I clinical trial for treating epilepsy. The company markets its products through wholesalers and distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Khattar Jack A.President, CEOAug 23Buy26.397,200189,982465,141Aug 27 05:27 PM
SIEBERT JOHN MDirectorJun 20Option Exercise9.1310,00091,30055,742Jun 24 08:06 PM
SIEBERT JOHN MDirectorApr 25Option Exercise9.1310,00091,30045,742Apr 29 03:43 PM
PATRICK GREGORY SSr VP, Chief Financial OfficerFeb 27Option Exercise9.1320,000182,60067,896Feb 28 04:29 PM
PATRICK GREGORY SSr VP, Chief Financial OfficerFeb 27Sale41.5320,000830,65047,896Feb 28 04:29 PM
CompanyTown Sports International Holdings, Inc.
IndustrySporting Activities
Market Cap66.35MEPS (ttm)-0.20
P/E-EPS this Y-98.20%
Forward P/E-EPS next Y34.50%
PEG-EPS past 5Y-64.20%
P/S0.14EPS next 5Y10.00%
P/B-EPS Q/Q-340.80%
Dividend-Sales Q/Q5.70%
Insider Own7.51%Inst Own71.00%
Insider Trans20.77%Inst Trans-0.16%
Short Float8.92%EarningsOct 31
Analyst Recom-Target Price3.00
Avg Volume151.34K52W Range1.11 - 8.13
Nov-05-19 06:25PMTown Sports (CLUB) Reports Q3 Loss, Lags Revenue Estimates Zacks
Nov-05-19 04:01PMTown Sports International Holdings, Inc. Reports Third Quarter 2019 Results Business Wire
Oct-25-19 08:29AMWhat Kind Of Shareholders Own Town Sports International Holdings, Inc. (NASDAQ:CLUB)? Simply Wall St.
Oct-17-19 10:33AMTown Sports (CLUB) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
Sep-19-19 10:27AMHave Insiders Been Buying Town Sports International Holdings, Inc. (NASDAQ:CLUB) Shares This Year? Simply Wall St.
Aug-14-19 09:09AMDoes Town Sports International Holdings, Inc. (NASDAQ:CLUB) Have A Particularly Volatile Share Price? Simply Wall St.
Jul-25-19 06:45PMTown Sports (CLUB) Reports Q2 Loss, Misses Revenue Estimates Zacks
Jul-18-19 10:33AMAnalysts Estimate Town Sports (CLUB) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-05-19 03:46PMIf You Had Bought Town Sports International Holdings (NASDAQ:CLUB) Stock A Year Ago, You'd Be Sitting On A 83% Loss, Today Simply Wall St.
Jun-28-19 08:06PMIs Town Sports International Holdings, Inc. (CLUB) A Good Stock To Buy ? Insider Monkey
Town Sports International Holdings, Inc., together with its subsidiaries, owns and operates fitness clubs in the Northeast and Mid-Atlantic regions of the United States. The company's clubs offer special purpose rooms for group fitness classes; and other exercise programs, as well as accommodate cardiovascular and strength-training equipment. Its clubs also provide amenities, including swimming pools, racquet and basketball courts, and functional training zones, as well as babysitting services; and fee-based program services, which comprise personal and small group training, children's programs, and summer camps for kids. The company sells its memberships through direct sales at the club level, as well as corporate and group sales; and through its online Website. As of December 31, 2018, it owned and operated 185 fitness clubs. Town Sports International Holdings, Inc. was founded in 1973 and is based in Jupiter, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walsh PatrickChief Executive OfficerSep 16Buy1.9616,60732,5502,500,434Sep 18 07:00 PM
Walsh PatrickChief Executive OfficerAug 28Buy1.8768,550128,4082,483,827Aug 28 08:56 PM
Walsh PatrickChief Executive OfficerAug 27Buy1.87110,310206,6552,415,277Aug 28 08:56 PM
Walsh PatrickChief Executive OfficerAug 26Buy1.52216,266329,5682,304,967Aug 28 08:56 PM
Walsh PatrickChief Executive OfficerMay 02Buy3.5840,681145,6952,088,701May 02 06:55 PM
CompanyVapotherm, Inc.
Market Cap229.51MEPS (ttm)-2.84
P/E-EPS this Y-35.90%
Forward P/E-EPS next Y9.70%
PEG-EPS past 5Y-
P/S5.06EPS next 5Y46.70%
P/B7.26EPS Q/Q-12.00%
Dividend-Sales Q/Q13.20%
Insider Own4.70%Inst Own66.60%
Insider Trans-Inst Trans0.20%
Short Float3.64%EarningsNov 05/a
Analyst Recom1.00Target Price26.33
Avg Volume196.94K52W Range8.30 - 24.63
Nov-05-19 04:01PMVapotherm Reports Third Quarter 2019 Financial Results Business Wire
Nov-01-19 04:30PMNew Study Shows Vapotherm Hi-VNI® Technology Improved In-patient Participant Ambulation Recovery Time by 32.5% Versus Standard Oxygen Therapy Business Wire
Oct-31-19 02:13PMHedge Funds Have Never Been More Bullish On Vapotherm, Inc. (VAPO) Insider Monkey
Oct-15-19 04:02PMVapotherm to Report Third Quarter 2019 Financial Results Business Wire
Sep-06-19 03:15PMVapotherm Inc (VAPO) President & CEO Joseph Army Bought $100,000 of Shares
Sep-05-19 featured highlights include: ACM, K12, Vapotherm, Equity Commonwealth and Columbus McKinnon Zacks
Sep-04-19 09:05AMNew Analyst Coverage Puts Spotlight on These 5 Stocks Zacks
Aug-09-19 11:01AMWhat Percentage Of Vapotherm, Inc. (NYSE:VAPO) Shares Do Insiders Own? Simply Wall St.
Jul-29-19 07:16PMVapotherm, Inc. (VAPO) Q2 2019 Earnings Call Transcript Motley Fool
Jul-26-19 04:15PMVapotherm, Inc. to Host Earnings Call ACCESSWIRE
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
CompanyAltice USA, Inc.
IndustryTelecom Services - Domestic
Market Cap20.01BEPS (ttm)0.44
P/E71.90EPS this Y102.10%
Forward P/E30.68EPS next Y114.26%
PEG-EPS past 5Y-
P/S2.06EPS next 5Y-
P/B7.76EPS Q/Q197.30%
Dividend-Sales Q/Q3.70%
Insider Own0.20%Inst Own86.40%
Insider Trans-Inst Trans-0.92%
Short Float14.01%EarningsNov 05/a
Analyst Recom1.90Target Price33.37
Avg Volume5.07M52W Range15.15 - 31.78
Nov-06-19Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Nov-06-19Downgrade Barclays Overweight → Equal Weight $33 → $31
Nov-06-19Downgrade Atlantic Equities Overweight → Neutral
Nov-06-19 09:22AMAltice (ATUS) Q3 Earnings Match Estimates, Revenues Up Y/Y Zacks
Nov-06-19 05:30AMWhat Altice USA, Inc.'s (NYSE:ATUS) ROE Can Tell Us Simply Wall St.
Nov-05-19 09:51PMCORRECTING and REPLACING Altice USA Reports Third Quarter 2019 Results Business Wire
Nov-05-19 06:15PMAltice USA misses estimates, cuts full-year sales forecast; shares slide Reuters
Nov-04-19 04:10PMReminder: Altice USA to Hold Conference Call to Discuss Q3 2019 Results Business Wire
Nov-04-19 09:37AM5 Best Stocks To Buy Right Now According To Billionaire Einhorn Insider Monkey
Oct-31-19 09:00AMADTRAN (ADTN) Q3 Loss Wider Than Expected, Revenues Fall Y/Y Zacks
Oct-31-19 08:58AMViavi (VIAV) Q1 Earnings Beat Estimates, Revenues Grow Y/Y Zacks
Oct-31-19 08:30AMMotorola (MSI) Q3 Earnings Beat on Holistic Growth, View Up Zacks
Oct-29-19 11:16AMCorning (GLW) Q3 Earnings & Revenues Top Estimates, Fall Y/Y Zacks
Altice USA, Inc., together with its subsidiaries, provides broadband communications and video services in the United States. The company operates in two segments, Cablevision and Cequel. It delivers broadband, pay television, telephony services, Wi-Fi hotspot access, proprietary content, and advertising services to approximately 4.9 million residential and business customers. The company also offers wireless routers and Internet security software; and pay television services, which include delivery of broadcast stations and cable networks, and advanced digital pay television services, such as video-on-demand, high-definition channels, digital video recorder, and pay-per-view. In addition, it provides Ethernet, data transport, IP-based virtual private networks, Internet access, and telephony services; hosted telephony, managed Wi-Fi, managed desktop and server backup services; managed collaboration services, including audio and Web conferencing; managed services, including business email, hosted private branch exchange, Web space storage, and network security monitoring; data-driven television, digital, and other multi-platform advertising services; and data-driven and audience-based advertising solutions. Further, the company operates local news channels, as well as traffic and weather channels;, a destination for local news on the Web; and News 12, a mobile application, as well as provides technical operating services comprising dispatch, customer installations, disconnects, service changes, customer service visits, outside plant maintenance service, and design and construction services for HFC and FTTH infrastructure. It provides communications and video services under Optimum and Suddenlink brand names. Altice USA, Inc. was incorporated in 2015 and is headquartered in Long Island City, New York.
CompanyAvinger, Inc.
IndustryMedical Appliances & Equipment
Market Cap13.89MEPS (ttm)-10.89
P/E-EPS this Y95.50%
Forward P/E-EPS next Y6.00%
PEG-EPS past 5Y-
P/S1.69EPS next 5Y-
P/B0.91EPS Q/Q91.20%
Dividend-Sales Q/Q9.50%
Insider Own0.80%Inst Own12.20%
Insider Trans0.00%Inst Trans143.78%
Short Float0.65%EarningsNov 12/a
Analyst Recom1.50Target Price4.25
Avg Volume486.17K52W Range0.77 - 12.60
Nov-05-19 04:01PMAvinger Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-31-19 06:52AMTry Rising P/E Investing With 5 Top-Ranked Stocks Zacks
Oct-29-19 09:00AMAvinger to Announce Third Quarter 2019 Financial Results on November 5, 2019 ACCESSWIRE
Oct-24-19 09:00AMAvinger (AVGR) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Oct-24-19 07:31AMTop Ranked Momentum Stocks to Buy for October 24th Zacks
Oct-18-19 10:23AMThese 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals
Oct-17-19 07:27AMGo Beyond Bargains: Play 5 Stocks With Rising P/E Instead Zacks
Oct-09-19 08:00AMAvinger Expands US Reach with Seven New Accounts in Third Quarter ACCESSWIRE
Sep-18-19 08:00AMAvinger Announces Full Commercial Launch of Pantheris SV ACCESSWIRE
Sep-17-19 08:00AMAvinger to Present at Ladenburg Thalmann Healthcare Conference on September 24 ACCESSWIRE
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
CompanyANI Pharmaceuticals, Inc.
Market Cap950.08MEPS (ttm)1.44
P/E54.65EPS this Y22.10%
Forward P/E13.35EPS next Y3.23%
PEG20.24EPS past 5Y27.40%
P/S4.42EPS next 5Y2.70%
P/B4.50EPS Q/Q126.50%
Dividend-Sales Q/Q15.00%
Insider Own2.90%Inst Own92.80%
Insider Trans-33.21%Inst Trans0.20%
Short Float15.53%EarningsNov 06/b
Analyst Recom1.70Target Price83.67
Avg Volume170.74K52W Range36.92 - 86.96
Nov-06-19 09:55AMANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue Estimates Zacks
Oct-31-19 08:30AMANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias PR Newswire
Oct-30-19 08:30AMANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results PR Newswire
Oct-29-19 10:33AMANI Pharmaceuticals (ANIP) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
Oct-29-19 08:30AMANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business PR Newswire
Oct-28-19 04:14PMHere is What Hedge Funds Think About ANI Pharmaceuticals Inc (ANIP) Insider Monkey
Oct-12-19 08:26AMDoes ANI Pharmaceuticals (NASDAQ:ANIP) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-11-19 featured highlights include: Assurant, Opera, ANI, eXp and Avista Zacks
Oct-09-19 09:09AM5 Stocks to Consider as New Analysts Initiate Coverage Zacks
Oct-03-19 08:30AMANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study PR Newswire
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncolytics (anti-cancers), hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 20Sale68.185,512375,8082,219,259Aug 21 06:11 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 19Sale68.302,067141,1762,224,771Aug 21 06:11 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 16Sale68.0926,3491,794,1032,226,838Aug 16 05:38 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 15Sale69.349,315645,9022,253,187Aug 16 05:38 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 14Sale69.8926,3601,842,3002,262,502Aug 16 05:38 PM
1 2 3 4 5 6 7 8 9 10 next